Literature DB >> 26883393

Total syntheses of codonopsinine and 4-epi-codonopsinine via gold-mediated tandem-catalyzed pyrrole synthesis.

Minami Yamaguchi1, Daichi Itagaki1, Hirofumi Ueda1, Hidetoshi Tokuyama1.   

Abstract

The total syntheses of codonopsinine (1) and 4-epi-codonopsinine (2) were accomplished. The key substituted pyrrole intermediate was constructed via gold-catalyzed addition-cyclization cascade of an aminoacetaldehyde acetal derivative and a terminal alkyne. After diastereoselective reduction of the pyrrole intermediate to the corresponding 3-pyrroline derivative with zinc dust and sulfonic acid, the total synthesis of 4-epi-codonopsinine (2) was achieved via stereoselective construction of the diol by dihydroxylation. In addition, the total synthesis of codonopsinine (1) was completed through stereochemical inversion of the hydroxyl group via epoxide and subsequent ring cleavage under the acidic aqueous condition.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26883393     DOI: 10.1038/ja.2016.13

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  11 in total

1.  Catalytic asymmetric direct Henry reaction of ynals: short syntheses of (2S,3R)-(+)-xestoaminol C and (-)-codonopsinines.

Authors:  Daisuke Uraguchi; Shinji Nakamura; Takashi Ooi
Journal:  Angew Chem Int Ed Engl       Date:  2010-10-04       Impact factor: 15.336

2.  Protecting-group-free total synthesis of (-)-rhazinilam and (-)-rhazinicine using a gold-catalyzed cascade cyclization.

Authors:  Kenji Sugimoto; Kazuki Toyoshima; Shiori Nonaka; Kenta Kotaki; Hirofumi Ueda; Hidetoshi Tokuyama
Journal:  Angew Chem Int Ed Engl       Date:  2013-06-06       Impact factor: 15.336

3.  An easy route to synthetic analogues of radicamine B, codonopsine and codonopsinine from D-mannitol.

Authors:  Suresh Dharuman; Ashok Kumar Palanivel; Yashwant D Vankar
Journal:  Org Biomol Chem       Date:  2014-07-21       Impact factor: 3.876

4.  Heck arylation of endocyclic enecarbamates with diazonium salts. Improvements and a concise enantioselective synthesis of (-)-codonopsinine.

Authors:  E A Severino; C Roque D Correia
Journal:  Org Lett       Date:  2000-10-05       Impact factor: 6.005

5.  Intramolecular [4 + 2] cycloadditions of 1,3-enynes or arylalkynes with alkenes with highly reactive cationic phosphine Au(I) complexes.

Authors:  Cristina Nieto-Oberhuber; Salomé López; Antonio M Echavarren
Journal:  J Am Chem Soc       Date:  2005-05-04       Impact factor: 15.419

6.  A short, efficient, and stereoselective total synthesis of a pyrrolidine alkaloid: (-)-codonopsinine.

Authors:  Jangari Santhosh Reddy; Batchu Venkateswara Rao
Journal:  J Org Chem       Date:  2007-02-23       Impact factor: 4.354

7.  Two new pyrrolidine alkaloids, radicamines A and B, as inhibitors of alpha-glucosidase from Lobelia chinensis Lour.

Authors:  M Shibano; D Tsukamoto; A Masuda; Y Tanaka; G Kusano
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-10       Impact factor: 1.645

8.  Iterative organometallic addition to chiral hydroxylated cyclic nitrones: highly stereoselective syntheses of alpha,alpha'- and alpha,alpha-substituted hydroxypyrrolidines.

Authors:  Andrea Goti; Stefano Cicchi; Vanni Mannucci; Francesca Cardona; Francesco Guarna; Pedro Merino; Tomas Tejero
Journal:  Org Lett       Date:  2003-10-30       Impact factor: 6.005

9.  Autotandem catalysis: synthesis of pyrroles by gold-catalyzed cascade reaction.

Authors:  Hirofumi Ueda; Minami Yamaguchi; Hiroshi Kameya; Kenji Sugimoto; Hidetoshi Tokuyama
Journal:  Org Lett       Date:  2014-09-09       Impact factor: 6.005

10.  In vitro inhibitory and cytotoxic activity of MFM 501, a novel codonopsinine derivative, against Methicillin-Resistant Staphylococcus aureus clinical isolates.

Authors:  Saiful Azmi Johari; Mastura Mohtar; Sharifah Aminah Syed Mohammad; Rohana Sahdan; Zurina Shaameri; Ahmad Sazali Hamzah; Mohd Fazli Mohammat
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.